Author:
Eberhardt W.E,Albain K.S,Pass H,Putnam J.B,Gregor A,Assamura H,Mornex F,Senan S,Belderbos J,Westeel V,Thomas M,Van Schil P,Vansteenkiste J,Manegold C,Mirimanoff R.O,Stuschke M,Pignon J,Rocmans P,Shepherd F.A
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference23 articles.
1. Induction therapy for NSCLC;Klastersky;Lung Cancer,1991
2. Induction therapy for stage III NSCLC: a consensus report;Green;Lung Cancer,1994
3. Induction treatment for resectable non-small-cell lung cancer;Perry;Lung Cancer,1997
4. Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805;Albain;Proc. Am. Soc. Clin. Oncol.,1999
5. Induction chemotherapy with MVP in patients with stage IIIa (T1-3, N2, M0) unresectable non small cell lung cancer (NSCLC): the Toronto experience;Burkes;Proc. Am. Soc. Clin. Oncol.,2000
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献